Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: secondary analysis of the geparsixto randomized clinical trial
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
October 2017
|
| In: |
JAMA oncology
Year: 2017, Volume: 3, Issue: 10, Pages: 1378-1385 |
| ISSN: | 2374-2445 |
| DOI: | 10.1001/jamaoncol.2017.1007 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1001/jamaoncol.2017.1007
|
| Author Notes: | Eric Hahnen, PhD, Bianca Lederer, PhD, Jan Hauke, PhD, Sibylle Loibl, MD, Sandra Kröber, Andreas Schneeweiss, MD, Carsten Denkert, MD, Peter A. Fasching, MD, Jens U. Blohmer, MD, Christian Jackisch, MD, Stefan Paepke, MD, Bernd Gerber, MD, Sherko Kümmel, MD, Christian Schem, MD, Guido Neidhardt, MSc, Jens Huober, MD14, Kerstin Rhiem, MD, Serban Costa, MD, Janine Altmüller, MD, Claus Hanusch, MD, Holger Thiele, MD, Volkmar Müller, MD, Peter Nürnberg, PhD,,Thomas Karn, MD, Valentina Nekljudova, PhD, Michael Untch, MD, Gunter von Minckwitz, MD, Rita K. Schmutzler, MD |
| Item Description: | Gesehen am 16.05.2018 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 2374-2445 |
| DOI: | 10.1001/jamaoncol.2017.1007 |